메뉴 건너뛰기




Volumn 373, Issue 9, 2015, Pages 882-

The safety of the blood supply-time to raise the bar

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN;

EID: 84940539917     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1507761     Document Type: Letter
Times cited : (10)

References (5)
  • 1
    • 84929377783 scopus 로고    scopus 로고
    • The safety of the blood supply-time to raise the bar
    • Snyder EL, Stramer SL, Benjamin RJ. The safety of the blood supply-time to raise the bar. N Engl J Med 2015;372:1882-5.
    • (2015) N Engl J Med , vol.372 , pp. 1882-1885
    • Snyder, E.L.1    Stramer, S.L.2    Benjamin, R.J.3
  • 2
    • 77954322802 scopus 로고    scopus 로고
    • Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction
    • Kerkhoffs JL, van Putten WL, Novotny VM, et al. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol 2010;150:209-17.
    • (2010) Br J Haematol , vol.150 , pp. 209-217
    • Kerkhoffs, J.L.1    Van Putten, W.L.2    Novotny, V.M.3
  • 3
    • 84940502802 scopus 로고    scopus 로고
    • Center for Biologics Evaluation and Research, Food and Drug Administration, Department of Health and Human Services. FDA summary of safety and effectiveness data (SSED): PMA BP140143, INTERCEPT Blood System for Platelets. December 18, 2014
    • Center for Biologics Evaluation and Research, Food and Drug Administration, Department of Health and Human Services. FDA summary of safety and effectiveness data (SSED): PMA BP140143, INTERCEPT Blood System for Platelets. December 18, 2014 (http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketApprovalsPMAs/UCM431243.pdf).
  • 4
    • 84941804676 scopus 로고    scopus 로고
    • Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion-transmitted bacterial strains
    • May 27 (Epub ahead of print)
    • Schmidt M, Hourfar MK, Sireis W, et al. Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion-transmitted bacterial strains. Transfusion 2015 May 27 (Epub ahead of print).
    • (2015) Transfusion
    • Schmidt, M.1    Hourfar, M.K.2    Sireis, W.3
  • 5
    • 83555176238 scopus 로고    scopus 로고
    • Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test
    • Jacobs MR, Smith D, Heaton WA, Zantek ND, Good CE. Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion 2011;51:2573-82.
    • (2011) Transfusion , vol.51 , pp. 2573-2582
    • Jacobs, M.R.1    Smith, D.2    Heaton, W.A.3    Zantek, N.D.4    Good, C.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.